{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T18:19:39Z","timestamp":1792865979021,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,4,20]],"date-time":"2007-04-20T00:00:00Z","timestamp":1177027200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Anti-cyclic citrullinated peptide (anti-CCP) antibodies have been of diagnostic value in Northern European Caucasian patients with rheumatoid arthritis (RA). In these populations, anti-CCP antibodies are associated with the HLA-DRB1 shared epitope. We assessed the diagnostic value of anti-CCP antibodies in Greek patients with RA where the HLA shared epitope was reported in a minority of patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Using an enzyme-linked immunosorbent assay (ELISA) (CCP2) kit, we tested anti-CCP antibodies in serum samples from 155 Greek patients with RA, 178 patients with other rheumatic diseases, and 100 blood donors. We also determined rheumatoid factor (RF) and compared it to anti-CCP antibodies for area under the curve (AUC), sensitivity, specificity and likelihood ratios.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Sensitivity of anti-CCP2 antibodies and RF for RA was 63.2% and 59.1%, and specificity was 95.0% and 91.2%, respectively. When considered simultaneously, the AUC for anti-CCP antibodies was 0.90 with 95% CI of 0.87 to 0.93 and the AUC for RF was 0.71 with 95% CI of 0.64 to 0.77. The presence of both antibodies increased specificity to 98.2%. Anti-CCP antibodies were positive in 34.9% of RF-negative RA patients. Anti-CCP antibodies showed a correlation with the radiographic joint damage. Anti-CCP-positive RA patients had increased the swollen joint count and serum CRP concentration compared to anti-CCP-negative RA patients (Mann-Whitney U test, p = 0.01, and p &lt; 0.001, respectively). However, no correlation was found between anti-CCP antibodies and DAS28 score (r = 0.13, p = 0.12).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>In Greek patients with RA, anti-CCP2 antibodies exhibit a better diagnostic value than RF and a correlation with radiological joint damage and therefore are useful in everyday rheumatology practice.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2474-8-37","type":"journal-article","created":{"date-parts":[[2007,4,30]],"date-time":"2007-04-30T15:55:30Z","timestamp":1177948530000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis"],"prefix":"10.1186","volume":"8","author":[{"given":"Ioannis","family":"Alexiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Germenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Ziogas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Theodoridou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lazaros I","family":"Sakkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,4,20]]},"reference":[{"key":"314_CR1","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/art.10148","volume":"46","author":"ACR subcommittee on RA Guidelines","year":"2002","unstructured":"ACR subcommittee on RA Guidelines: Guidelines for the management of rheumatoid arthritis. Arthritis Rheum. 2002, 46: 328-46. 10.1002\/art.10148.","journal-title":"Arthritis Rheum"},{"issue":"suppl 2","key":"314_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/ar551","volume":"4","author":"G Steiner","year":"2002","unstructured":"Steiner G, Smolen J: Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res. 2002, 4 (suppl 2): S1-S5. 10.1186\/ar551.","journal-title":"Arthritis Res"},{"key":"314_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1568-9972(02)00128-3","volume":"2","author":"MA van Boekel","year":"2003","unstructured":"van Boekel MA, van Venrooij WJ: Modifications of arginine and their role in autoimmunity. Autoimmine Rev. 2003, 2: 57-62. 10.1016\/S1568-9972(02)00128-3.","journal-title":"Autoimmine Rev"},{"key":"314_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","volume":"43","author":"GA Schellekens","year":"2000","unstructured":"Schellekens GA, Visser H, de Jong BAW, van den Hoogen FHJ, Hazes JMW, Breedveld FC, van Venrooij WJ: The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000, 43: 155-63. 10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3.","journal-title":"Arthritis Rheum"},{"key":"314_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/art.10117","volume":"46","author":"H Visser","year":"2002","unstructured":"Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JMW: How to diagnose rheumatoid arthritis early. A prediction model for persistent (erosive) arthritis. Arthritis Rheum. 2002, 46: 357-65. 10.1002\/art.10117.","journal-title":"Arthritis Rheum"},{"key":"314_CR6","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/ard.62.9.870","volume":"62","author":"DM Lee","year":"2003","unstructured":"Lee DM, Schur PH: Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis. 2003, 62: 870-74. 10.1136\/ard.62.9.870.","journal-title":"Ann Rheum Dis"},{"key":"314_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/03009740310003677","volume":"32","author":"K Suzuki","year":"2003","unstructured":"Suzuki K, Sawada T, Murakami A, Matsui T, Tohma S, Nakazono K, Takemura M, Takasaki Y, Mimori T, Yamamoto K: High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis. Scan J Rheumatol. 2003, 32: 197-204. 10.1080\/03009740310003677.","journal-title":"Scan J Rheumatol"},{"key":"314_CR8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/ard.2003.008623","volume":"63","author":"S Dubucquoi","year":"2004","unstructured":"Dubucquoi S, Solau-Gervais E, Lefranc D, Marguerie L, Sibilia J, Goetz J, Dutoit V, Fauchais A-L, Hachulla E, Flipo R-M, Prin L: Evaluation of the anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatoid arthritis. Ann Rheum Dis. 2004, 63: 415-19. 10.1136\/ard.2003.008623.","journal-title":"Ann Rheum Dis"},{"key":"314_CR9","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1136\/ard.2003.016808","volume":"63","author":"A Kastbom","year":"2004","unstructured":"Kastbom A, Strandberg G, Lindroos A, Skogh T: Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis. 2004, 63: 1085-89. 10.1136\/ard.2003.016808.","journal-title":"Ann Rheum Dis"},{"key":"314_CR10","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1136\/ard.2003.019877","volume":"63","author":"I Vallbracht","year":"2004","unstructured":"Vallbracht I, Rieber J, Oppermann M, F\u00f6rger F, Siebert U, Helmke K: Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann Rheum Dis. 2004, 63: 1079-84. 10.1136\/ard.2003.019877.","journal-title":"Ann Rheum Dis"},{"key":"314_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/rheumatology\/kei111","volume":"45","author":"AJW Zendman","year":"2006","unstructured":"Zendman AJW, van Venrooij WJ, Pruijn GJM: Use and significance of anti-CCP autoantibodies in rheumatoid arhritis. Rheumatology. 2006, 45: 20-25. 10.1093\/rheumatology\/kei111.","journal-title":"Rheumatology"},{"key":"314_CR12","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1136\/ard.2003.017574","volume":"63","author":"L De Rycke","year":"2004","unstructured":"De Rycke L, Peene I, Hoffman IEA, Kruithof E, Union A, Meheus L, Lebeer K, Vincent C, Mielants H, Boullart L, Serre G, Veys EM, de Keyser F: Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis:diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis. 2004, 63: 1587-93. 10.1136\/ard.2003.017574.","journal-title":"Ann Rheum Dis"},{"key":"314_CR13","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1136\/ard.2003.014233","volume":"63","author":"K Forslind","year":"2004","unstructured":"Forslind K, Ahlm\u00e9n M, Eberhardt K, Hafstr\u00f6m I, Svensson B, for the BARFOT study group: Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis. 2004, 63: 1090-95. 10.1136\/ard.2003.014233.","journal-title":"Ann Rheum Dis"},{"key":"314_CR14","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1002\/art.20316","volume":"50","author":"FA van Gaalen","year":"2004","unstructured":"van Gaalen FA, van Aken J, Huizinga TWJ, Schreuder GMTH, Breedveld FC, Zanelli E, van Venrooij WJ, Verweij CL, Toes REM, de Vries RRP: Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influence the severity of rheumatoid arthritis. Arthritis Rheum. 2004, 50: 2113-21. 10.1002\/art.20316.","journal-title":"Arthritis Rheum"},{"key":"314_CR15","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1136\/ard.2004.033571","volume":"64","author":"J Ronnelid","year":"2005","unstructured":"Ronnelid J, Wick MC, Lampa J, Lindblad S, Nordmark B, Klareskog L, van Vollenhoven RF: Longitudinal analysis of citrullinated protein\/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis. 2005, 64: 1744-49. 10.1136\/ard.2004.033571.","journal-title":"Ann Rheum Dis"},{"key":"314_CR16","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/art.1780350706","volume":"35","author":"KA Boki","year":"1992","unstructured":"Boki KA, Panayi GS, Vaughan RW, Drosos AA, Moutsopoulos HM, Lanchbury JS: HLA class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks. The HLA-DR beta shared-epitope hypothesis accounts for the disease in only a minority of Greek patients. Arthritis Rheum. 1992, 35: 749-55. 10.1002\/art.1780350706.","journal-title":"Arthritis Rheum"},{"key":"314_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchel DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-24. 10.1002\/art.1780310302.","journal-title":"Arthritis Rheum"},{"key":"314_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL: Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995, 38: 44-48. 10.1002\/art.1780380107.","journal-title":"Arthritis Rheum"},{"key":"314_CR19","first-page":"1974","volume":"22","author":"A Larsen","year":"1995","unstructured":"Larsen A: How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in long-term studies?. J Rheumatol. 1995, 22: 1974-75.","journal-title":"J Rheumatol"},{"key":"314_CR20","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/028418517701800415","volume":"18","author":"A Larsen","year":"1977","unstructured":"Larsen A, Dale K, Eek M: Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh). 1977, 18: 481-491.","journal-title":"Acta Radiol Diagn (Stockh)"},{"key":"314_CR21","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/art.20044","volume":"50","author":"FA Van Gaalen","year":"2004","unstructured":"Van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CL, Toes REM, Huizinga TWJ: Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthtitis. Arthritis Rheum. 2004, 50: 709-15. 10.1002\/art.20044.","journal-title":"Arthritis Rheum"},{"key":"314_CR22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1172\/JCI1316","volume":"101","author":"GA Schellekens","year":"1998","unstructured":"Schellekens GA, de Jong BAW, van den Hoogen FHJ, van de Putte LBA: Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest. 1998, 101: 273-81.","journal-title":"J Clin Invest"},{"issue":"6","key":"314_CR23","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/clinchem\/47.6.1089","volume":"47","author":"N Bizzaro","year":"2001","unstructured":"Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R: Diagnostic accuracy of anti-citrulline antibody assay for rheumatoid arthritis. Clinical Chemistry. 2001, 47 (6): 1089-93.","journal-title":"Clinical Chemistry"},{"key":"314_CR24","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1136\/ard.2003.014647","volume":"63","author":"C Alessandri","year":"2004","unstructured":"Alessandri C, Bombardieri M, Papa N, Cinquini M, Magrini L, Tincani A, Valestini G: Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFa therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement. Ann Rheum Dis. 2004, 63: 1218-21. 10.1136\/ard.2003.014647.","journal-title":"Ann Rheum Dis"},{"key":"314_CR25","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1002\/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6","volume":"43","author":"E-JJA Kroot","year":"2000","unstructured":"Kroot E-JJA, de Jong BAW, van Leeuwen MA, Swinkels H, van den Hoogen FHJ, van't Hof M, van de Putte LBA, van Rijswijk MH, van Venrooij WJ, van Riel PLCM: The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 2000, 43: 1831-35. 10.1002\/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6.","journal-title":"Arthritis Rheum"},{"key":"314_CR26","doi-asserted-by":"publisher","first-page":"R303","DOI":"10.1186\/ar1187","volume":"6","author":"E Berglin","year":"2004","unstructured":"Berglin E, Padyukov L, Sundin U, Hallmans G, Stenlund H, van Venrooij WJ, Klareskog L, Rantapaa-Dahlqvist S: A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res Ther. 2004, 6: R303-R308. 10.1186\/ar1187.","journal-title":"Arthritis Res Ther"},{"key":"314_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1365-2249.2004.02341.x","volume":"135","author":"O Vittecoq","year":"2004","unstructured":"Vittecoq O, Incaurgarat B, Jouen-Beades F, Legoedec J, Letourneur O, Rolland D, Gervasi G, Menard JF, Gayet A, Fardellone P, Daragon A, Jolivet M, Le Loet X, Tron F: Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis. Clin Exp Immunol. 2004, 135: 173-80. 10.1111\/j.1365-2249.2004.02341.x.","journal-title":"Clin Exp Immunol"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-8-37.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2474-8-37\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-8-37","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-8-37.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T22:25:12Z","timestamp":1630448712000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/1471-2474-8-37"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,20]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["314"],"URL":"https:\/\/doi.org\/10.1186\/1471-2474-8-37","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,20]]},"assertion":[{"value":"5 November 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"37"}}